Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Edesa Biotech Inc
EDSA
Healthcare
Biotechnology
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing...
non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07, a monoclonal antibody, which is in a Phase 2 clinical study for the treatment of pulmonary fibrosis; and EB06, a human monoclonal antibody candidate that binds to chemokine ligand 10 (CXCL10) and inhibits the interaction of CXCL10 with its receptors, CXCR3A, and CXCR3B. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:EDSA)
New Post
View:
Posts & Comments
Threaded Posts
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 13, 2025 12:41pm
Sold out of this stock today.Wow.
Got out of this one at $3.76 cents per share.
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 13, 2025 8:47am
Buy buddy buy because it's taking off this morning.
So good luck to all of you guys out there.
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 24, 2025 11:37am
Using technical analysis for this stock.
This stock is a big bargain for me at these low prices.BUY buddy buy before it is too late for you fellas out there.Wow.
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 8:48am
Edesa Biotech, Inc. (NASDAQ:EDSA): A Promising Biopharmaceut
https://beyondspx.com/2024/08/01/edesa-biotech-inc-nasdaqedsa-a-promising-biopharmaceutical-company-advancing-innovative-therapies/
(35)
•••
ferret_ca
X
Comment by
ferret_ca
on Dec 22, 2021 1:38pm
RE:EDSA ..... NR this a.m.... up ~ $2...... On watch
EDSA looks very interesting with huge potential, I've initiated a position over the last week or so. looks like not many are onto this at all. cheers ferret
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 19, 2021 9:00am
EDSA ..... NR this a.m.... up ~ $2...... On watch
Trading at $9.40 on 2.8 million shares in the Pre-market No position Watching & waiting
(2)
•••
aee
X
Comment by
aee
on Oct 04, 2021 12:08pm
RE:News
or not. No one noticed. Is there life here?
(2)
•••
aee
X
Post by
aee
on Sep 20, 2021 3:40pm
News
Well, this should make for interesting fireworks once the news reports on it tonight.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Podcasts